Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes

References

• Goey AK Mooiman KD Beijnen JH Schellens JH Meijerman I Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients Cancer Treat Rev 2013 39 7 773 783 23394826
   PubMed Web of Science ®Google Scholar
• Gouws C Steyn D Du Plessis L Steenekamp J Hamman JH Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux Expert Opin Drug Metab Toxicol 2012 8 8 973 984 22612723
   PubMed Web of Science ®Google Scholar
• Mukherjee PK Ponnusankar S Pandit S Hazam PK Ahmmed M Mukherjee K Botanicals as medicinal food and their effects on drug metabolizing enzymes Food Chem Toxicol 2011 49 12 3142 3153 21959528
   PubMed Web of Science ®Google Scholar
• Na DH Ji HY Park EJ Kim MS Liu KH Lee HS Evaluation of metabolism-mediated herb-drug interactions Arch Pharm Res 2011 34 11 1829 1842 22139684
   PubMed Web of Science ®Google Scholar
• Mohamed ME Frye RF Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies Planta Med 2011 77 4 311 321 21049395
   PubMed Web of Science ®Google Scholar
• Zhou SF Zhou ZW Li CG Identification of drugs that interact with herbs in drug development Drug Discov Today 2007 12 15–16 664 673 17706549
   PubMed Web of Science ®Google Scholar
• Chen XW Serag ES Sneed KB Clinical herbal interactions with conventional drugs: from molecules to maladies Curr Med Chem 2011 18 31 4836 4850 21919844
   PubMed Web of Science ®Google Scholar
• Rahimi R Abdollahi M An update on the ability of St John’s wort to affect the metabolism of other drugs Expert Opin Drug Metab Toxicol 2012 8 6 691 708 22606944
   PubMed Web of Science ®Google Scholar
• Wang X Zhang H Chen L Shan L Fan G Gao X Liquorice, a unique “guide drug” of traditional Chinese medicine: a review of its role in drug interactions J Ethnopharmacol 2013 150 3 781 790 24201019
   PubMed Web of Science ®Google Scholar
• Zadoyan G Rokitta D Klement S Effect of Ginkgo biloba special extract EGb 761(R) on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers Eur J Clin Pharmacol 2012 68 5 553 560 22189672
   PubMed Web of Science ®Google Scholar
• Russo E Scicchitano F Whalley BJ Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions Phytother Res 2014 28 5 643 655 23897801
   PubMed Web of Science ®Google Scholar
• Zhang Z Ge B Zhou L Lam TN Zuo Z Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin J Ethnopharmacol 2014 154 3 672 686 24832110
   PubMed Web of Science ®Google Scholar
• Muller AC Kanfer I Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines Biopharm Drug Dispos 2011 32 8 458 470 22024968
   PubMed Web of Science ®Google Scholar
• Zhou X Chan K Yeung JH Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes Drug Metabol Drug Interact 2012 27 1 9 18 22718621
   PubMedGoogle Scholar
• Chow HH Garland LL Hsu CH Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study Cancer Prev Res 2010 3 9 1168 1175
   PubMed Web of Science ®Google Scholar
• Wu JW Lin LC Tsai TH Drug-drug interactions of silymarin on the perspective of pharmacokinetics J Ethnopharmacol 2009 121 2 185 193 19041708
   PubMed Web of Science ®Google Scholar
• Haefeli WE Carls A Drug interactions with phytotherapeutics in oncology Expert Opin Drug Metab Toxicol 2014 10 3 359 377 24387348
   PubMed Web of Science ®Google Scholar
• Unger M Pharmacokinetic drug interactions involving Ginkgo biloba Drug Metab Rev 2013 45 3 353 385 23865865
   PubMed Web of Science ®Google Scholar
• Grime K Ferguson DD Riley RJ The use of HepaRG and human hepatocyte data in predicting CYP induction drug-drug interactions via static equation and dynamic mechanistic modelling approaches Curr Drug Metab 2010 11 10 870 885 21208171
   PubMed Web of Science ®Google Scholar
• Honma M Kozawa M Suzuki H Methods for the quantitative evaluation and prediction of CYP enzyme induction using human in vitro systems Expert Opin Drug Discov 2010 5 5 491 511 22823132
   PubMed Web of Science ®Google Scholar
• Klieber S Torreilles F Guillou F Fabre G The use of human hepatocytes to investigate drug metabolism and CYP enzyme induction Methods Mol Biol 2010 640 295 308 20645059
   PubMedGoogle Scholar
• Zhu BT On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations Expert Opin Drug Metab Toxicol 2010 6 4 483 494 20113197
   PubMed Web of Science ®Google Scholar
• Hukkanen J Induction of cytochrome P450 enzymes: a view on human in vivo findings Expert Rev Clin Pharmacol 2012 5 5 569 585 23121279
   PubMed Web of Science ®Google Scholar
• Mattinen L Kublbeck J Rechardt O Honkakoski P Rautio J Direct and rapid transcript analysis assay for CYP mRNA expression and inducibility in human primary hepatocytes Drug Metab Lett Epub 2014 6 15
   Google Scholar
• Gerin B Dell’Aiera S Richert L Smith S Chanteux H Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy Xenobiotica 2013 43 4 320 335 23153057
   PubMed Web of Science ®Google Scholar
• Einolf HJ Chen L Fahmi OA Evaluation of various static and dynamic modeling methods to predict clinical CYP3A induction using in vitro CYP3A4 mRNA induction data Clin Pharmacol Ther 2014 95 2 179 188 23995268
   PubMed Web of Science ®Google Scholar
• Halladay JS Wong S Khojasteh SC Grepper S An ‘all-inclusive’ 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes J Pharmacol Toxicol Meth 2012 66 3 270 275
   PubMed Web of Science ®Google Scholar
• Zhang JG Ho T Callendrello AL Evaluation of calibration curve-based approaches to predict clinical inducers and non-inducers of CYP3A4 using plated human hepatocytes Drug Metab Dispos 2014 42 9 1379 1391 24924386
   PubMed Web of Science ®Google Scholar
• Shen C Meng Q Prediction of cytochrome 450 mediated drug-drug interactions by three-dimensional cultured hepatocytes Mini Rev Med Chem 2012 12 10 1028 1036 22512564
   PubMed Web of Science ®Google Scholar
• Koe XF Lim EL Seah TC Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L Food Chem Toxicol 2013 60 98 108 23876819
   PubMed Web of Science ®Google Scholar
• Komoroski BJ Zhang S Cai H Induction and inhibition of cytochromes P450 by the St John’s wort constituent hyperforin in human hepatocyte cultures Drug Metab Dispos 2004 32 5 512 518 15100173
   PubMed Web of Science ®Google Scholar
• Komoroski BJ Parise RA Egorin MJ Strom SC Venkataramanan R Effect of the St John’s wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures Clin Cancer Res 2005 11 19 Pt 1 6972 6979 16203790
   PubMed Web of Science ®Google Scholar
• Srovnalova A Svecarova M Kopecna Zapletalova M Effects of anthocyanidins and anthocyanins on the expression and catalytic activities of CYP2A6, CYP2B6, CYP2C9, and CYP3A4 in primary human hepatocytes and human liver microsomes J Agric Food Chem 2014 62 3 789 797 24387788
   PubMed Web of Science ®Google Scholar
• Williamson B Dooley KE Zhang Y Back DJ Owen A Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine Antimicrob Agents Chemother 2013 57 12 6366 6369 24060875
   PubMed Web of Science ®Google Scholar
• Takusagawa S Miyashita A Iwatsubo T Usui T In vitro inhibition and induction of human cytochrome P450 enzymes by mirabegron, a potent and selective beta3-adrenoceptor agonist Xenobiotica 2012 42 12 1187 1196 22834478
   PubMed Web of Science ®Google Scholar
• Arora S Singh S Piazza GA Contreras CM Panyam J Singh AP Honokiol: a novel natural agent for cancer prevention and therapy Curr Mol Med 2012 12 10 1244 1252 22834827
   PubMed Web of Science ®Google Scholar
• Chilampalli C Zhang X Kaushik RS Chemopreventive effects of combination of honokiol and magnolol with alpha-santalol on skin cancer developments Drug Discov Ther 2013 7 3 109 115 23917859
   PubMedGoogle Scholar
• Tian W Xu D Deng YC Honokiol, a multifunctional tumor cell death inducer Pharmazie 2012 67 10 811 816 23136712
   PubMed Web of Science ®Google Scholar
• Kumar A Kumar Singh U Chaudhary A Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities Future Med Chem 2013 5 7 809 829 23651094
   PubMed Web of Science ®Google Scholar
• Guerra-Araiza C Alvarez-Mejia AL Sanchez-Torres S Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases Free Radic Res 2013 47 6–7 451 462 23594291
   PubMed Web of Science ®Google Scholar
• Shen JL Man KM Huang PH Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders Molecules 2010 15 9 6452 6465 20877235
   PubMed Web of Science ®Google Scholar
• Chen YJ Tsai KS Chan DC Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes J Orthop Res 2014 32 4 573 580 24375705
   PubMed Web of Science ®Google Scholar
• Kim BH Cho JY Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression Acta Pharmacol Sin 2008 29 1 113 122 18158873
   PubMed Web of Science ®Google Scholar
• Zhang P Liu X Zhu Y Chen S Zhou D Wang Y Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-kappaB activation and cytokine production of glial cells Neurosci Lett 2013 534 123 127 23262090
   PubMed Web of Science ®Google Scholar
• Hu H Zhang XX Wang YY Chen SZ Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin Acta Pharmacol Sin 2005 26 9 1063 1068 16115372
   PubMed Web of Science ®Google Scholar
• Woodbury A Yu SP Wei L Garcia P Neuro-modulating effects of honokiol: a review Front Neurol 2013 4 130 24062717
   PubMed Web of Science ®Google Scholar
• Li N Xie H Li L Effects of honokiol on sepsis-induced acute kidney injury in an experimental model of sepsis in rats Inflammation 2014 37 4 1191 1199 24531855
   PubMed Web of Science ®Google Scholar
• Lin YR Chen HH Lin YC Ko CH Chan MH Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain J Biomed Sci 2009 16 94 19832997
   PubMed Web of Science ®Google Scholar
• Matsui N Takahashi K Takeichi M Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice Brain Res 2009 1305 108 117 19815000
   PubMed Web of Science ®Google Scholar
• Lee YJ Lee YM Lee CK Jung JK Han SB Hong JT Therapeutic applications of compounds in the Magnolia family Pharmacol Ther 2011 130 2 157 176 21277893
   PubMed Web of Science ®Google Scholar
• Xu Q Yi LT Pan Y Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents Prog Neuropsychopharmacol Biol Psychiatry 2008 32 3 715 725 18093712
   PubMed Web of Science ®Google Scholar
• Dong Y Tang M Song H Characterization of metabolic profile of honokiol in rat feces using liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and (13)C stable isotope labeling J Chromatogr B 2014 953–954 20 29
   Web of Science ®Google Scholar
• Lai H Tang M Liu J Identification of honokiol metabolites in rats by the method of stable isotope cluster technique and ultra-high performance liquid chromatography/quadrupole-time-of-flight mass spectrometry J Chromatogr B 2013 931 157 163
   Web of Science ®Google Scholar
• Liu J Tang M Lai H Identification of metabolites of honokiol in rat urine using 13C stable isotope labeling and liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry J Chromatogr A 2013 1295 48 56 23618226
   PubMed Web of Science ®Google Scholar
• Jeong HU Kong TY Kwon SS Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes Molecules 2013 18 9 10681 10693 24005963
   PubMed Web of Science ®Google Scholar
• Ji HY Liu KH Jeong JH Effect of a new prokinetic agent DA-9701 formulated with corydalis tuber and pharbitidis semen on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes Evid Based Complement Alternat Med 2012 2012 650718 22548118
   PubMed Web of Science ®Google Scholar
• Xu C Li CY Kong AN Induction of phase I, II and III drug metabolism/transport by xenobiotics Arch Pharm Res 2005 28 3 249 268 15832810
   PubMed Web of Science ®Google Scholar
• Obach RS Inhibition of human cytochrome P450 enzymes by constituents of St John’s Wort, an herbal preparation used in the treatment of depression J Pharmacol Exp Ther 2000 294 1 88 95 10871299
   PubMed Web of Science ®Google Scholar
• Madabushi R Frank B Drewelow B Derendorf H Butterweck V Hyperforin in St John’s wort drug interactions Eur J Clin Pharmacol 2006 62 3 225 233 16477470
   PubMed Web of Science ®Google Scholar
• Turpeinen M Zanger UM Cytochrome P450 2B6: function, genetics, and clinical relevance Drug Metab Drug Interact 2012 27 4 185 197
   Google Scholar